irinotecan csc infusioonilahuse kontsentraat
gp-pharm s.a. - irinotekaan - infusioonilahuse kontsentraat - 20mg 1ml 15ml 1tk; 20mg 1ml 5ml 1tk; 20mg 1ml 2ml 1tk; 20mg 1ml 25ml 1tk
oxaliplatin csc infusioonilahuse pulber
gp-pharm s.a. - oksaliplatiin - infusioonilahuse pulber - 5mg 1ml 50mg 1tk; 5mg 1ml 100mg 1tk
gemcitabine csc 1000 mg infusioonilahuse pulber
gp-pharm s.a. - gemtsitabiin - infusioonilahuse pulber - 1000mg 1tk
gemcitabine csc 200 mg infusioonilahuse pulber
gp-pharm s.a. - gemtsitabiin - infusioonilahuse pulber - 200mg 1tk
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastilised ained - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
vidprevtyn beta
sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - vaktsiinid - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 ja 5. 1 in product information document). kasutamist see vaktsiin peaks olema kooskõlas ametlike soovitustega.
ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
tepkinly
abbvie deutschland gmbh & co. kg - epcoritamab - lymphoma, large b-cell, diffuse - antineoplastilised ained - tepkinly as monotherapy is indicated for the treatment of adult patients with relapsed or refractory diffuse large b-cell lymphoma (dlbcl) after two or more lines of systemic therapy.
vepacel
ology bioservices ireland ltd - gripiviirus (kogu virion, inaktiveeritud), mis sisaldab antigeeni: a / vietnam / 1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - gripivaktsiinid - aktiivne immuniseerimine gripiviiruse h5n1 alatüübi vastu. see näidustus põhineb immunogenicity andmeid teemasid alates vanusest 6 kuud aastast pärast manustamist kaks annust vaktsiini, mis on valmistatud alatüübi h5n1 tüve. vepacel tuleks kasutada vastavalt euroopa liidu arendus.